Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Antibiotic drug interactions.

Manjunath P Pai¹, Kathryn M Momary, Keith A Rodvold

¹University of New Mexico, College of Pharmacy, MSC09 5360, Albuquerque, NM 87131, USA.

The Medical Clinics of North America

|November 23, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Challenging Weight-Tiered Antibiotic Prophylaxis in Obese Patients Undergoing Colorectal Surgery Using CT-Derived Body Composition.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

Toward the Future: A Race-Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing.

Clinical pharmacology and therapeutics·2026

Same author

Clinical Impact of Linezolid Therapeutic Drug Monitoring on the Tolerability of Prolonged Courses in the Outpatient Setting.

Open forum infectious diseases·2026

Same author

Optimizing dalbavancin dosing for complicated methicillin-resistant Staphylococcus aureus infections: a multicentre population pharmacokinetic study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

Same author

Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling.

Antimicrobial agents and chemotherapy·2026

Same author

Plasma and intrapulmonary pharmacokinetics of ceftibuten and ledaborbactam in healthy male and female adults.

Antimicrobial agents and chemotherapy·2026

Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026

Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026

Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026

Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026

Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026

Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026

See all related articles

Drug interactions in infectious disease treatment are growing. This review covers interaction principles and specific examples with antibacterial, antiviral, and tuberculosis drugs.

Area of Science:

Pharmacology
Infectious Diseases
Drug Metabolism

Background:

Drug-drug interactions (DDIs) in infectious diseases are increasingly complex.
New drugs, identified metabolic pathways, and revised guidelines necessitate updated DDI knowledge.

Purpose of the Study:

To provide an overview of DDI principles and mechanisms.
To describe common pharmacokinetic-pharmacodynamic (PK/PD) interactions in infectious disease therapy.

Main Methods:

Literature review of DDI principles.
Analysis of PK/PD interactions for key drug classes.

Main Results:

Overview of DDI mechanisms (e.g., enzyme/transporter effects).
Common DDIs identified for antibacterials, non-retroviral antivirals, and tuberculosis medications.

Related Experiment Videos

Conclusions:

Understanding DDIs is crucial for safe and effective infectious disease management.
Clinicians must stay informed about evolving DDI profiles for optimal patient outcomes.